Ubiquitination affects various immune processes and E3 ubiquitin ligases (E3) play an important role in determining substrate specificity. We identified 11 human E3 ligase genes of potential importance in pathogenesis of autoimmune diseases by search of public databases and screened them for candidacy of biological investigation with case-control linkage disequilibrium tests on multiple SNPs in the genes using rheumatoid arthritis (RA) as a model of autoimmune diseases. Significant association with RA was observed in an SNP in intron 3 of Cullin 1 (CUL1) that affected transcriptional efficiency of the promoter activity in lymphocytic cell lines. Quantitative expression analysis revealed that CUL1 mRNA was highly detected in lymphoid tissues including spleen and tonsil, and was specifically expressed in T and B lymphocytes in fractionated peripheral leukocytes. Histological evaluation of tonsils indicated that CUL1 protein expression was relatively specific for maturing germinal centers. Suppression of CUL1 expression had influence on the phenotype of T-cell line, that is, it inhibited IL-8 induction, which is known to play an important role in the migration of inflammatory cells into the affected area seen in RA. Our data suggest that the regulation of CUL1 expression in immunological tissues may affect the susceptibility of RA via altering lymphocyte signal transduction.
Introduction
The ubiquitin system contributes to many aspects of cellular activities. The length of the ubiquitin chain is generally related to different processes. Whereas at least four units of the ubiquitin chain seem necessary for proteasomal degradation, 1 mono-ubiquitination is involved in endocytosis. 2 The ubiquitin-proteasome system degrades polyubiquitinated proteins via the 26S protein complex, the proteasome. The machinery contributes to a variety of cellular processes, including cellcycle control, signal transduction, transcriptional regulation, DNA repair, antigen presentation and apoptosis. 3 In addition to physiologically normal proteins, misfolded proteins could be substrates in the cellular stress response, through which E3s constitute a protein quality control system. 4 However, other regulatory roles such as internalization of the receptor protein, [5] [6] [7] transcription stimulation 8, 9 and protein processing 10, 11 via ubiquitination have recently been suggested.
Ubiquitin is a small peptide of 76 amino acids that is highly conserved in all eukaryotes. The ubiquitin pathway proceeds through a three-step enzymatic cascade involving ubiquitin-activating enzyme (E1), ubiquitinconjugating enzyme (E2) and ubiquitin ligase (E3). While there are only dozens of E2s, E3s are highly heterogeneous. This feature allows these enzymes to determine specific ubiquitin interactions with its target proteins 12 that control cell processes such as activation, proliferation and differentiation.
The ubiquitination system is also involved in many aspects of the immune system. For example, antigens processed by polyubiquitination are presented on the surfaces of antigen-presenting cells (APCs) that are recognized by MHC class I molecules of cytotoxic T cells. Proteasome and tripeptidyl aminopeptidase II (TPPII) might cooperate to produce peptides bound by MHC class I proteins. 13, 14 E3 ubiquitin ligases are also involved in the NF-kB signaling pathway that regulates the expression of various genes during inflammation, immunity, differentiation and apoptosis. The activation cascade is also modulated by the multiple ubiquitination system executed by E3s. In response to proinflammatory cytokines, TRAF6 modified by polyubiquitin chains is essential for TAK1 kinase activation, which leads to IkB kinase (IKK) phosphorylation. 15, 16 The activation of IKK causes the phosphorylation and degradation of IkBa, followed by NF-kB activation. The SCF (Skp1-Cullin1-Fbox)
b-TrCP E3 complex participates in IkBa degradation. 17, 18 Furthermore, another ubiquitin ligase might execute the proteolysis of NF-kB p105 into active subunits to translocate into the nucleus and regulate target gene transcription. 19 Recently it has been found that adaptor protein Bcl10, which is essential for NF-kB activation by T-and B-cell receptors, promotes NF-kB activation through the paracaspase-and UBC13-dependent ubiquitination of NEMO (IKK-g). 20 Some E3s play regulatory roles in T-cell anergy. For example, GRAIL suppresses and limits activation-induced IL-2 and IL-4 production in T-cell hybridomas. 21 The constitutive expression of GRAIL renders naive CD4T cells anergic. 22 T cells derived from E3 Itch À/À mice are activated and their proliferation is enhanced, which results in severe immune and inflammatory disorders and constant itching of the skin. 23 Furthermore, c-Cbl and Cbl-b negatively regulate T-cell activation by promoting the clearance of engaged TCR from the cell surface by ubiquitination, 24 and Cbl-b negatively regulates BCR signaling by targeting Syk for ubiquitination. 25 As shown above, E3s are involved in immune processes. We identified CUL1 among E3s as a candidate of autoimmunity-related gene by screening association between SNPs and rheumatoid arthritis (RA). RA is a widespread autoimmune disease that affects 0.5-1.0% of the worldwide population. It is characterized by chronic inflammation of the synovial joints due to the infiltration of lymphocytes, macrophages and plasma cells, accompanied by hyperplasia of the synovial fibroblasts. The pathology of RA is generally defined by the activities of many inflammatory cytokines. The ubiquitin system might be involved in RA because the overexpression of the E3 ubiquitin ligase, Synoviolin/Hrd1, causes the excessive growth of synoviocytes in mice, which leads to spontaneous arthropathy. 26 One risk factor for RA is genetic contribution. The susceptibility of siblings of affected individuals and of monozygotic twins is higher than that of the general population. Genetic studies of RA using SNPs have revealed RA-susceptible SNPs such as PADI4, 27 RUNX1 and SLC22A4, 28 and PTPN22. 29 Therefore, to identify the E3s involved in autoimmune diseases, we performed a case-control linkage disequilibrium study of the Japanese RA population. We discovered an SNP associated with RA in CUL1, a component of the SCF E3 complex. CUL1 is highly conserved from nematodes to humans, 30 and it is indispensable for mouse embryogenesis.
31 CUL1 binds to the Skp1-F-box protein complex and to ROC1 through its N-and C-terminal region, respectively. F-box is a member of a large family of substrate-targeting proteins that determine the specificity of E3 activity. ROC1, on the other hand, recruits an E2 enzyme and functions as a ubiquitin ligase on its substrate. 32 A structural characteristic of the E3 ligase is the RING finger motif in ROC1. 33 Besides IkBa, 17, 18 SCF complex has several targets, including b-catenin, 16 p27, CyclinE1 34 and IFNa receptor 1. 6 Thus, SCF has been studied as an inflammation or/and cell cycle modulator.
Here, we analyze the expression and function of CUL1 in the context of the immune system in autoimmunity.
Results
Analysis of RA-related SNPs in E3 ubiquitin ligase Screening of E3 ubiquitin ligase genes for association with RA with SNPs. A total of 11 E3 ubiquitin ligase genes were selected as described in Materials and methods. Table 1 lists the SNPs and the genotyping results. All the SNPs were polymorphic in Japanese population, with a minor allele frequency more than 0.08% except for #31 in GRAIL. Among 33 SNPs in the 11 selected genes, only one SNP (#8) in intron 3 of the CUL1 gene was significantly associated with RA, with Po0.0005 (corrected Po0.05 by Bonfferoni correction). Based on these results, we selected CUL1 for further analysis for function and mechanism in immune system. SNP mapping in CUL1 locus. To investigate the region around CUL1, we analyzed the LD and haplotype structure with the genotype data of 40 SNPs for 94 case samples ( Figure 1 ). SNPs with a moderately strong LD (D40.5) to #8 were distributed in both CUL1 and its neighboring gene EZH2. We then searched for SNPs in this region using the JSNP database, which mainly focuses on SNPs in the 5 0 UTR, 3 0 UTR and the coding region. 35 We also directly sequenced 2 kb of the 5 0 -flanking region and exon 1, in 48 genomic samples from RA patients to find functional SNPs in the promoter region. Thus, among 40 genotyped SNPs, only intron 3 of CUL1 contained SNPs with a P-value of o0.001. Furthermore, no SNPs were associated with RA in the CUL1 coding, or 5 0 and 3 0 flanking regions ( Figure 1 ). Therefore, SNP #8 in intron 3 of CUL1 could affect susceptibility to RA. We therefore examined the functional differences of associated SNP #8.
Reporter assay of RA-associated SNP in CUL1. Reporter constructs containing one, five or nine concatenated copies of the 24 nucleotides around the associated SNP #8 were connected to the SV40 promoter ( Figure 2a ). The constructs were transiently transfected into both the Jurkat T-cell ( Figure 2b ) and Raji B-cell (Figure 2c ) lines. The susceptible C allele had more enhancer activity than the nonsusceptible A allele in both cell lines, with statistical significance Po0.005 for five and nine concatenated constructs.
Expression of CUL1
Quantitative RT-PCR. To elucidate the role of CUL1 in inflammatory disease, we analyzed the mRNA expression level using quantitative real-time PCR. The expression levels of CUL1 mRNA in a human tissue panel were high in the spleen, tonsils and in whole blood, and moderate in the brain, thymus, bone marrow and liver. The kidneys and heart expressed low levels of CUL1 mRNA (Figure 3a) . Synovial fibroblast cells from RA patients also expressed moderate levels of CUL1. Mononuclear cells in the peripheral blood expressed more CUL1 mRNA than polynuclear cells and lymphocyte-dominant expression of CUL1 was further ascertained with expression evaluation of fractionated cells stratified with cell surface markers CD4, 8, 14 and 19 ( Figure 3b ).
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Immunohistochemistry.
To further investigate subtypes of lymphocytes expressing CUL1, we examined tonsil sections using immunohistochemical staining (Figure  3c-g ). Well-structured germinal centers were observed in the sections with hematoxylin-eosin staining (data not shown) and anti-CD20 and anti-CD3 antibody staining (Figure 3c and d respectively) . Germinal centers were immunohistologically divided into two types. One type was clearly structured with CD23-positive cells, and the other was not. We counted 30 CD23-positive germinal centers and 14 CD23-negative germinal centers (Figure 3e ). Although expression of CUL1 was principally detected in germinal centers, where B-cells dominated (Figure 3f) , not all germinal centers were positive with anti-CUL1 antibody signal. CUL1-positive fraction among germinal centers was 77% (34 out of 44) and the ratio was different between CD23-positive and -negative germinal centers. CUL1-positive germinal centers were more likely to be CD23-positive (28 out of 30) than CD23-negatives (six out of 14). The difference seemed to indicate that CUL1 expression was regulated along with germinal center maturation.
CUL1 siRNA inhibits IL-8 production in Jurkat cells
To investigate the role of CUL1 in lymphocytic cells, we interrupted CUL1 expression by siRNA transfection. Transfection of siRNA into Jurkat cells induced decrease of CUL1 protein with dose dependency and the decrease was observed 24 h after transfection, and it persisted up to 72 h after the transfection. Suppression of ubiquitination activity of the SCF complex was measured by accumulation of p27, which was a known substrate of the Roc1-Skp1-CUL1-F-box (Skp2) complex (Figure 4a ). As a control to evaluate substrate specificity, we used the CDK2 protein that interacts with p27 in the G1 to S transition state and is not degraded by the complex. 36 In contrast to p27, CDK2 kept a steady level in spite of CUL1 siRNA transfection. The specificity of the siRNA was confirmed by lack of change in the amount of CUL1 and p27 protein by transfection of a control siRNA against the luciferase gene. IL-8 is one of the cytokines that are known to be induced in T cells by various stimulations. As shown in Figure 4b , CUL1 siRNA significantly suppressed IL-8 mRNA induction in Jurkat cells stimulated with PMA and PHA in a dosedependent manner (Figure 4b ) (Po0.05).
Discussion
The present study showed that the regulation of E3 ubiquitin ligase CUL1 expression in immunological tissues might affect susceptibility to autoimmune RA via an associated SNP in intron 3 of CUL1. We searched the databases for SNP in the CUL1 gene and its regulatory region from the promoter and from the first to the last exon including the intron. 35 However, we found SNPs only in the intron region. As CUL1 is highly conserved among organisms and plays an important role in mice embryogenesis, 31 the molecular functions of CUL1 as a component of the E3 ligase complex should be strictly regulated both qualitatively and quantitatively in vivo. We evaluated a sequence from 2 kb upstream from the transcription initiation site and exon 1 for the 
of human tonsils immunohistochemically stained as described in Materials and methods with anti-CD20 (c), anti-CD3 (d), anti-CD23 (e), anti-CUL1 (f) and isotype control rabbit IgG (g).
CUL1 as a susceptible gene in rheumatoid arthritis R Kawaida et al presence of SNPs in the region with regulatory elements. However, a functional SNP which had association with RA was never found in the coding or promoter regions of CUL1 (Figure 1 ). The associated SNP in intron 3 is probably involved in the subtle control of expression and might affect common disease susceptibility. Expression profiling revealed high levels of CUL1 expression in the spleen and tonsils, as well as in the T-and B-cell fraction of whole blood (Figure 3a and b) . Therefore, CUL1 might function as a modulator in the development and activation status of hematological cells. In addition, since CUL1 is involved in the regulation of centrosome replication in Drosophila neuroblasts, 37 moderate expression in the brain and liver might contribute to appropriate cell division in these tissues. From the viewpoint of lymphoid tissue, introducing the dominantnegative form of CUL1 into T-lineage cells causes lymphoid organ hypoplasia and reduced proliferation, followed by abnormal cell division. 36 Therefore, CUL1 contributes to T-lymphocyte division and proliferation. The relatively low level of CUL1 expression in CD14-positive monocytic cells suggests that another factor(s) plays a role in cell proliferation and/or NF-kB activation in addition to CUL1. We showed how CUL1 protein is expressed in human tonsils. In such secondary lymphoid tissues, germinal centers are specialized for the selection of antigen-specific B cells that leads to extensive expansion, isotype switching, somatic hypermutation and differentiation into plasma cells and memory cells. Germinal centers arise when B cells accumulate among the processes of follicular dendritic cells and undergo intense proliferation, apoptosis and hypermutation. B cells that produce high-affinity antibodies in response to antigen presented by T cells are selected to survive, while B cells that do not recognize antigen enter apoptosis. 38 In this structure, CD23 is an early-activation antigen marker of normal and activated B cells of the mantle zone, and follicular dendritic reticulum cells can be visualized by intense staining. The expression of CUL1 protein overlapped with CD20-positive B cells rather than CD3-positive T cells in the CD23-positive germinal center structure (Figure 3c-f) . Germinal center structures are ectopically generated in RA synovium tissue. 39 Therefore, CUL1 must play a role in B cells of mature, differentiated germinal centers during autoimmune status. This might help not only immature B cells to rapidly divide and cause B-cell expansion, but also mature B cells to survive through NF-kB activation.
The intron region in addition to SNPs in the promoter region might be involved in regulating the expression level of the gene. For example, SNPs in intron 1 of LGALS2 40 and LT-a 41 cause changes in transcriptional activity. A relationship between a sequence in the intron region and a ligand-responsive element has also been indicated in the ATP-binding cassette transporter G1. 42 We searched the promoter and exon region of CUL1, but did not detect any SNPs. As CUL1 is highly conserved, subtle changes in the intron region should affect expression levels of the gene. Therefore, we investigated the influence of SNP in intron 3 of CUL1 on transcriptional CUL1 as a susceptible gene in rheumatoid arthritis R Kawaida et al efficiency in lymphocytic cell lines. Allelic differences in SNP #8 in intron 3 influenced the enhancer-like activity in both T-and B-cell lines (Figure 2 ). These results from reporter assays and expression profiling indicate that #8 can affect the expression level of CUL1 in immunological tissues. Changing one nucleotide within the site from A (nonsusceptible allele) to C (susceptible allele) in #8 generated a score indicating that the binding probability to Ets-1 in the TRANSFAC databases 43 would increase from 71.1 to 87.0, respectively. Ets-1 might regulate T-cell survival and activation, as well as B-cell differentiation status. 44, 45 Enhanced CUL1 expression due to Ets-1 binding in intron 3 might alter T-and B-cell behavior in immunological tissue and/or blood that would cause a change to autoimmune status as described above.
To investigate the role of CUL1 in lymphoid cells, we suppressed CUL1 mRNA transcription by transfecting siRNA into a Jurkat T-cell line. This partially decreased the induction of IL-8 mRNA by PMA and PHA (Figure 4) . IL-8 is a cytokine with both chemotactic and angiogenic effects produced by T lymphocytes following activation. Transcription factor-binding sites have been identified in the promoter of the IL-8 gene. The sequence contains binding sequences for AP-1, C/EBP and NF-kB and confers an IL-8 promoter response to IL-1, TNF and PMA. 46 In addition, enhanced IL-8 production in RA synovial fibroblasts stimulated with IL-17 is transduced both via NF-kB and PI3-kinase/Akt. 47 The expression of IL-8 was partially inhibited probably due to accumulation of the CUL1 substrate IkBa, which leads to NF-kB inactivation. However, IL-2 and TNFa were not inhibited by siRNA (data not shown). The regulation of these cytokine levels might depend more on factors other than NF-kB when stimulated with PMA and PHA. These data suggest that CUL1 positively regulates chemokine IL-8 production by T cells in immunological tissues. Although B-cell lines were not functionally analyzed due to transfection difficulties, B-cell signaling might also be affected and altered by changes in CUL1 expression levels in structures like germinal centers during autoimmune status. B cells expressing higher levels of CUL1 probably tend to escape apoptosis through NF-kB hyperactivation.
In conclusion, we found that CUL1 is an E3 ubiquitin ligase that is predominantly expressed in T and B lymphocytes and its expression seems to be regulated by functional differentiation of lymphocytes. It might be responsible for susceptibility to RA through altering lymphocyte signal transduction. Comparisons of CUL1 expression between individuals with susceptible and nonsusceptible alleles and the generation of tissuespecific CUL1 knockdown and/or transgenic mice should help to define the role of CUL1 in autoimmune diseases.
Materials and methods

SNPs and genotyping E3 ubiquitin ligase genes
We screened E3 ubiquitin ligases as follows. Firstly, we searched NCBI Entrez Nucleotide database with keywords 'E3 ubiquitin ligase', 'Homo sapiens' (organism), 'biomol_mrna' (PROP) and 'srcdb_refseq' (PROP) and identified 91 human transcript nucleotide sequences. Among the 91 hits, we selected only 24 genes whose encoding proteins were previously reported to have E3 ubiquitin ligase activity by manually inspecting reference reports. We then scrutinized the genes using the SAGE Anatomic Viewer in the NCI Gene Finder Database. We finally selected 11 genes that express more than four clones per 200 000 clones from either lymph node or white blood cells. We selected 88 SNPs in these genes both by JSNP 35 and NCBI dbSNP databases. We recruited Japanese individuals with and without RA as described. 27 Using 94 case samples, we genotyped 88 SNPs and analyzed linkage disequilibrium (LD). Based on the results, we finally selected three SNPs per gene, which were mutually as independent as possible from the LD standpoint. We genotyped the selected 33 
Western blotting
To prepare whole cell extracts, cells were washed with phosphate-buffered saline, lysed in RIPA buffer (1% NP-40, 0.5% deoxycholic acid and 0.1% SDS in phosphatebuffered saline) supplemented with complete protease inhibitor cocktail (Roche Diagnostics), and then sedimented by centrifugation. Equal amounts of protein (10-15 mg) from the supernatant were separated in 5-20% gradient SDS-polyacrylamide gels and then electroblotted onto a polyvinylidene difluoride membrane (Bio-Rad). Proteins of interest were visualized using the ECL Plus Western blotting detection system (Amersham Pharmacia Biotech) according to the manufacturer's instructions.
Luciferase assay
Luciferase reporter plasmids were constructed by cloning single, five or nine concatenated copies of the adjacent 24 nucleotides of the SNP #8 nucleotide into the pGL3-promoter vector (Promega) upstream of the SV40 promoter. We also introduced KpnI or NheI sites at the 5 0 ends of sense or antisense oligonucleotides, respectively. The fidelity of the constructs was verified by nucleotide sequencing. Jurkat cells were transfected with 2 mg of either of the constructs and with 0.2 mg of the pRL-TK Renilla luciferase vector (Promega) to normalize transfection efficiency using DMRIE-C reagent (Invitrogen). After 5 h, the cells were incubated with PHA and PMA at final concentrations of 1 mg/ml and 50 ng/ml, respectively, for 16 h. Raji cells were transfected with the same plasmids described above using the A-23 program of Amaxa Nucleofectort (Amaxa) according to the manufacturer's instructions. The cells were incubated on the following day for 5 h with the same concentration of PHA and PMA as the Jurkat cells, and then cell extracts were prepared using Passive Lysis Buffer (Promega). Firefly and Renilla luciferase activities in the cell lysates were determined using a Dual-luciferase assay system (Promega) according to the supplier's instructions.
RNA interference assay
An RNA consisting of 21 nucleotides was chemically synthesized (TaKaRa) and the various amounts of siRNA was transiently transfected with C-16 program using the Amaxa Nucleofectort (Amaxa) according to the manufacturer's instructions. Cells were incubated on the following day with PHA and PMA at final concentrations of 1 mg/ml and 50 ng/ml, respectively, for 5 h. Total RNA was then extracted using the RNeasy Mini kit and an RNase-Free DNase set (QIAGEN) according to the instruction manual provided. First-strand cDNA was synthesized using oligo d(T) 16 primers and TaqMan Reverse Transcription Reagents (Applied Biosystems).
Quantitative real-time PCR TaqMan PCR proceeded using an ABI PRISM 7900 Sequence Detection System (Applied Biosystems) according to the manufacturer's instructions. TaqMan probes and primers were Assays-on-Demand gene expression products (Applied Biosystems). Preparation of rheumatoid synovial fibroblasts has been described. 49 The relative expression of CUL1 and IL-8 mRNA was normalized to the amount of GAPDH in the same cDNA using a standard curve or the DD method according to the manufacturer's instructions.
